Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Envista Holdings Corporation NVST

Healthcare — Medical Instruments & Supplies

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total sells
0.51
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — 1 — — — — — 1 —
Insider Ownership
3.11%

Capital & Financial Ratios

Market Cap
3,810.00
Revenue
2,856.50
Net Income
95.00
Free Cash Flow
249.00
Net Debt
310.70
Current Ratio
2.43
Debt/Equity
0.47
P/E ratio
39.58
P/S ratio
1.32
P/B ratio
1.23
Past 5Y EPS Growth
(6.72%)
This Y EPS Growth
28.79%
Next Y EPS Growth
8.71%
Next 5Y EPS Growth
15.21%
in millions of $

Dividends

Payout Ratio
0.00
Annual Dividend Rate
—
Annual Dividend Yield
—
total individual payouts
2025 ‡‡‡
2024 ‡‡‡
2023 ‡‡‡
2022 ‡‡‡
2021 ‡‡‡
2020 ‡‡‡
2019 ‡‡‡
2018 ‡‡‡
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 940.00 1,069.10 1,211.70 1,125.60
Receivables 407.50 363.00 429.60 436.90
Inventory 258.80 241.00 288.10 290.90
Other — — — —
1,743.70 1,788.30 2,026.60 1,958.00
2023 2024 2025 Q'26
Payables 179.50 174.60 191.60 190.20
ST’ Debt 115.30 116.00 — —
Other — — — —
780.80 878.70 852.60 807.30
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow — ‡‡‡‡‡ ‡‡‡‡‡
Earnings — ‡‡‡‡‡ ‡‡‡‡‡
Book Value — ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 705.50 730.50 — —
—
’25 616.90 682.10 669.90 750.60
2,719.50
’24 623.60 633.10 601.00 652.90
2,510.60
’23 627.20 662.40 631.30 645.60
2,566.50
’22 631.40 645.80 631.10 660.80
2,569.10
’21 612.60 637.20 607.30 651.80
2,508.90
’20 547.20 362.00 547.20 472.70
1,929.10
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (3.30) 119.20 — —
—
’25 0.30 88.70 78.70 108.00
275.70
’24 40.30 93.10 70.70 132.40
336.50
’23 3.10 75.10 95.50 102.00
275.70
’22 3.50 22.20 46.70 110.30
182.70
’21 16.60 120.70 88.30 136.00
361.60
’20 (62.30) 4.70 148.10 193.40
283.90
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 (15.70) 105.10 — —
—
’25 (5.10) 76.40 67.90 91.70
230.90
’24 29.30 86.30 63.30 123.90
302.80
’23 (14.40) 61.00 77.10 99.90
223.60
’22 (16.30) 10.10 21.40 95.10
110.30
’21 8.30 100.50 82.40 127.30
318.50
’20 (75.90) (3.10) 134.90 185.60
241.50
in millions of $

EPS

Mar Jun Sep Dec Year
’26 0.23 0.33 — —
—
’25 0.10 0.16 (0.18) 0.20
0.28
’24 0.14 (6.69) 0.05 0.01
(6.50)
’23 0.25 0.29 0.12 (1.27)
(0.60)
’22 0.42 0.26 0.27 0.42
1.37
’21 0.41 0.51 0.52 0.48
1.92
’20 (0.11) (0.59) 0.22 0.64
0.20

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

2.1
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 31.67 20.00 15.15 14.22 — — —
Low Price
— — — ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 52.03 43.29 25.64 22.68 — — —
High Price
— — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 12,700 12,800 12,300 12,000 — — —
Employees
‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.20 0.20 0.20 0.23 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,569.10 2,566.50 2,510.60 2,719.50 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 57.41% 56.13% 54.68% 54.67% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 283.90 (54.90) (1,084.70) 177.20 ‡‡‡‡‡ — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 11.05% (2.14%) (43.20%) 6.52% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 243.10 (100.20) (1,118.60) 47.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 166.20 167.20 159.40 154.90 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 15.77 15.38 14.58 16.19 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡ ‡‡‡‡ ‡‡‡ ‡‡‡‡ ‡‡‡‡ 1.49 (0.60) (6.50) 0.28 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.12 1.65 1.95 1.64 ‡‡‡‡ — —
Cash Flow/Sh
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.44) (0.31) (0.20) (0.27) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.68 1.34 1.76 1.37 — — —
Free CF/Sh
‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 25.83 25.01 17.04 18.49 ‡‡‡‡‡ — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 162.90 166.90 172.20 168.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 22.79 0.00 0.00 77.54 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.15 1.57 1.32 1.34 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ 1.32 0.96 1.13 1.17 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ 2.45 1.79 1.45 1.47 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 57.17 20.55 12.04 17.32 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 182.70 275.70 336.50 275.70 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (72.40) (52.10) (33.70) (44.80) ‡‡‡‡‡ ‡‡‡‡‡ —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 110.30 223.60 302.80 230.90 ‡‡‡‡‡ — —
FCF
— ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 187.90 962.90 909.60 1,174.00 — — —
Working Cap'
— — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,380.70 1,513.40 1,394.30 1,448.30 — — —
Total Debt
— — — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 773.80 573.40 325.20 236.60 — — —
Net Debt
— ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4,206.90 4,173.90 2,934.80 3,106.30 — — —
Sh' Equity
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.69% (1.52%) (18.71%) 0.85% ‡‡‡‡‡ — —
ROA
— ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.01% 0.41% (19.90%) 4.04% — — —
ROIC
‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.88% (2.39%) (31.47%) 1.56% ‡‡‡‡‡ — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Envista Holdings (NVST), the dental products powerhouse spun off from Danaher in 2019, has endured a wild ride: COVID-crushed revenues rebounded resiliently to stable $2.5B+ levels, only for a staggering $1.08B 2024 impairment charge to obliterate profits and crater ROE to -31%. Yet beneath the scars, consumables-driven revenue stability shines, with forecasts eyeing 8% growth to $2.72B in 2025 and steady climbs toward $3B by 2028, fueled by digital dentistry tailwinds and an aging population—outpacing medtech peers.

Cash flows tell a brighter tale, with FCF surging 35% to $303M in 2024, net debt slashed 79%, and multiples screaming bargain: PS at 1.3x, EV/FCF at 12x. Stock’s recent 30% pop above lows hints at rebound hopes, trading at fair forward PE if EPS flips positive by 2026. But skeptics beware: insider sells without a single buy signal tepid conviction, while implant softness and execution risks could trap value hunters in another leg down.

Is NVST a cash-rich turnaround gem or a post-impairment value trap? With analysts bullish yet shares eyeing 20% upside (or 35% downside), the full analysis unpacks if fundamentals reclaim 2021 glory amid M&A ghosts and sector storms.

Read full commentary →

Envista Holdings Corporation (NVST) Latest News

News by impact score

Fine-tune

25 Aug

3 , 12:30 PM
Envista Holdings reported Q2 earnings, prompting analysis on whether to buy, sell, or hold NVST shares based on results and outlook. Q2 earnings trigger investor reassessment of NVST financial trajectory and near-term positioning.

14 Aug

3 , 10:58 AM
Envista Holdings (NVST) faces questions on sustaining its 2026 guidance boost amid ongoing margin expansion. Guidance sustainability and margin trends can moderately shift financial outlook and sentiment.

3 , 7:01 AM
Envista Holdings Q2 earnings call featured analyst questions on financial performance, margins and strategic outlook. Q2 earnings discussion and analyst questions provide moderate insight into financial results and near-term outlook.

12 Aug

3 transcript www.fool.com, 5:28 PM
Envista Holdings Corporation (NVST) held its Q2 2026 earnings call covering financial results, operational updates and forward outlook. Quarterly earnings calls deliver financial metrics and guidance that can shift near-term investor sentiment and valuation.

9 Aug

4 , 5:08 PM
Envista Holdings Corporation posted strong Q2 results and raised its 2026 guidance. Strong Q2 results and raised 2026 guidance indicate a materially improved financial trajectory for Envista Holdings.

8 Aug

3 www.marketbeat.com, 6:03 PM
Envista Holdings Q2 earnings call highlights financial results and company outlook. Q2 earnings highlights typically influence short-term market sentiment without major strategic shifts.

6 Aug

4 , 1:02 AM
Envista Holdings Corp posted strong core growth in its Q2 2026 earnings call and raised full-year guidance. Strong core growth and raised guidance indicate major positive shifts in financial trajectory and investor sentiment.

3 transcript app.moby.co, 8:30 AM
Envista Holdings Corp held its Q2 2026 earnings call, covering financial results, operational performance, and forward guidance for the dental products company. Quarterly earnings calls deliver financial results and guidance that can shift short-term stock sentiment without guaranteeing long-term structural change.

5 Aug

3 , 9:00 PM
Envista Holdings (NVST) Q2 earnings show key metrics compared against estimates. Q2 metrics versus estimates may moderately shift views on financial performance.

3 , 4:27 PM
Envista Holdings (NVST) reported Q2 CY2026 sales exceeding analyst estimates. Sales beat provides moderate positive signal for near-term revenue trends and investor views.

3 , 4:05 PM
Envista Holdings Corporation (NVST) reported its second quarter 2026 financial results. Quarterly results provide updated financial metrics that can shift near-term stock valuation and sentiment.

13 Jul

3 , 9:34 AM
Envista Holdings (NVST) ranked first in Q1 dental equipment and technology earnings. Sector-leading Q1 earnings ranking lifts short-term sentiment and visibility for NVST.

3 Jun

3 Zacks, 11:16 AM
NVST stock faces identified growth drivers alongside risks that could shape performance through 2026. Forward-looking growth drivers and risks analysis may moderately influence NVST market sentiment and trajectory.

22 May

3 Simply Wall St., 9:15 PM
New small-cap fund backing and margin focus may alter the bull case for Envista Holdings (NVST). New fund backing and margin focus can moderately shift NVST market sentiment and operations.

13 May

4 www.marketbeat.com, 5:06 AM
Envista Holdings Corporation (NVST) released highlights from its Q1 earnings call, covering financial results, guidance, and strategic updates. Q1 earnings call highlights disclose financial performance and outlook, significantly influencing investor sentiment and stock trajectory.

12 May

3 StockStory, 4:04 PM
Envista Holdings Corporation (NVST) delivered strong Q1 revenue growth, but the market remains cautious due to macroeconomic headwinds and tariff risks. Strong Q1 revenue growth boosts financials but is counterbalanced by macro and tariff concerns limiting broader trajectory shifts.

7 May

4 app.moby.co, 8:30 AM
Envista Holdings Corp released Q1 2026 earnings call summary highlighting financial performance, guidance, and strategic updates. Q1 2026 earnings details and forward guidance directly shape investor sentiment and NVST stock trajectory.

6 May

4 Zacks, 7:00 PM
Key metrics from Envista Holdings Corporation (NVST) Q1 earnings reveal insights into the company's financial performance and operational health. Q1 earnings metrics significantly impact NVST's financial trajectory and investor sentiment.

4 Zacks, 6:30 PM
Envista Holdings Corporation (NVST) beat Q1 earnings and revenue estimates. Surpassing Q1 earnings and revenue estimates boosts investor sentiment and signals strong financial performance.

4 StockStory, 4:16 PM
Envista (NYSE:NVST) posted better-than-expected sales in Q1 CY2026. Beating Q1 CY2026 sales expectations delivers significant positive signal on financial health and boosts market sentiment.

4 PR Newswire, 4:05 PM
Envista Holdings Corporation reported first quarter 2026 results. Quarterly earnings reports disclose key financial metrics that significantly influence NVST's stock performance and investor outlook.

5 May

4 Simply Wall St., 8:14 AM
Envista Holdings (NVST) delivered a broad-based earnings beat with strong operating leverage, positioning it as a potential game changer for future performance and market standing. Broad-based earnings beat and operating leverage indicate significant enhancements in financial efficiency and growth potential, likely to positively alter NVST's trajectory and investor sentiment.

3 Simply Wall St., 11:15 AM
Envista Holdings (NVST) narrative shifts as analysts revise views and fair value estimates evolve. Evolving analyst views and fair value estimates moderately influence investor sentiment and NVST's market trajectory.

3 May

4 , 12:20 PM
Envista Holdings Corp. (NVST) stock jumps after beating earnings expectations, driven by accelerating market share gains. Earnings beat combined with accelerating market share gains indicates significant positive shift in competitive positioning and investor sentiment.

27 Apr

4 StockStory, 8:44 PM
Envista (NYSE:NVST) reported the strongest Q4 results from its Dental Equipment & Technology Group. Strongest Q4 results in core Dental Equipment & Technology Group signal significant positive impact on financial performance and market trajectory.

16 Apr

4 ACCESS Newswire, 2:30 PM
Kerr Dental launches ZenSeal Pro with ZenSave Tips, optimizing canal efficiency and reducing waste in endodontic procedures. New product launch improves endodontic efficiency and cuts waste, strengthening Envista's dental segment competitiveness.

4 ACCESS Newswire, 1:00 PM
Kerr Dental, an Envista Holdings Corporation brand, launched Demi Pro, a cordless dental curing light with a flexible, light-weight arm that follows the dentist's movements for enhanced ergonomics, faster workflows, and reduced fatigue during procedures. Launch of innovative ergonomic curing light strengthens Envista's competitive position in dental equipment through product innovation.

31 Mar

3 Zacks, 1:40 PM
Envista Holdings Corporation (NVST) offers compelling reasons for immediate addition to investment portfolios, highlighting strong growth potential and undervaluation. Bullish recommendation targets investor sentiment and short-term stock performance without altering core operations.

30 Mar

4 Zacks, 10:51 AM
Envista Holdings Corporation (NVST) stock surged 42.5% over the past year, fueled by strong operational performance, strategic initiatives, and favorable market conditions. 42.5% stock gain highlights major positive drivers poised to significantly shape NVST's future performance and investor sentiment.

12 Mar

4 Zacks, 12:00 PM
Envista Holdings Corporation (NVST) rating upgraded to Strong Buy by analysts, providing comprehensive details on the company's strengths, financials, and growth prospects. Analyst upgrade to Strong Buy boosts investor sentiment and could significantly enhance NVST's market performance and stock trajectory.
© 2016–2026 stockrow.com Terms and Conditions Indicators Weekly Summary Contact Us